Showing results (501-510 of 738) with videos related to
Sort By:
Pageof 74
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.Neurobiology of Aging|July 15, 2020
Gray matter changes related to microglial activation in Alzheimer's diseaseNicolas Nicastro, Maura Malpetti, Elijah Mak, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 4, 2016
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's DiseaseRobin J Borchert, Timothy Rittman, Luca Passamonti, et al.Cell Reports|February 20, 2026
Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathiesDorothea Böken, Melissa Huang, Yunzhao Wu, et al.Annals of Clinical and Translational Neurology|October 24, 2018
[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansionRichard W Bevan-Jones, Thomas E Cope, Simon P Jones, et al.Nature Communications|November 11, 2024
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseasesEvgeniia Lobanova, Yu P Zhang, Derya Emin, et al.Journal of Neurology|March 26, 2025
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonismDavid P Vaughan, Raquel Real, Marte Theilmann Jensen, et al.Neuroimage|March 22, 2002
Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractographyGeoffrey J M Parker, Klaas E Stephan, Gareth J Barker, et al.Brain Communications|September 6, 2021
[18F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseasesElijah Mak, Antonina Kouli, Negin Holland, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 1, 2019
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical featuresAudrey Low, Elijah Mak, Maura Malpetti, et al.Pageof 74